This observational cohort study analyzed polygenic risk scores (PRS) for anxiety disorders and major depression in participants from the UK Biobank and the Norwegian Mother, Father, and Child Cohort (MoBa). The sample included 7,486 with major depression only, 1,992 with anxiety only, 3,468 with comorbid anxiety-depression, and 85,851 controls.
The PRS for major depression showed a stronger association with comorbid anxiety-depression cases versus major depression-only cases (Z=-2.82, adjusted p=0.01). Similarly, the PRS for anxiety showed a stronger association with comorbid cases versus anxiety-only cases (Z=-2.36, adjusted p=0.03). The PRS for major depression-only was more strongly associated with major depression-only cases than anxiety-only cases (Z=3.63, adjusted p=6.9e-04).
Genetic correlation between anxiety-only and major depression-only was rg=0.53 (SE=0.11), while it was higher between comorbid anxiety and comorbid depression (rg=0.91, SE=0.01). Mendelian randomization suggested bidirectional causal effects were attenuated to null when comorbid states were excluded. Gene set enrichment for immune regulation (interleukin-21 production) was found in major depression-comorbid, anxiety-comorbid, and major depression-only groups, but not in anxiety-only.
Safety data were not reported. Key limitations include the observational design, which cannot establish causation, and the lack of follow-up duration. Findings underscore the importance of disorder-specific genetic studies for precision medicine, but these implications require further validation.
View Original Abstract ↓
Background The extensive genetic overlap between anxiety disorders (ANX) and major depression (MD) may partly reflect inclusion of comorbid cases in genome-wide association studies (GWAS). We investigated this genetic relationship between ANX and MD with and without mutual comorbidity. Methods Using UK Biobank, we performed disorder-specific GWAS for ANX-only (cases/controls = 9,980/179,442) and MD-only (cases/controls = 15,301/179,038) and derived polygenic risk scores (PRS). In the Norwegian Mother, Father, and Child Cohort (MoBa), we tested associations of PRS with MD-only (N=7,486), ANX-only (N=1,992), and comorbid (ANX-MD) (N=3,468) and controls (N=85,851). PRS associations with anxiety and depression symptoms were tested in MoBa (N=54,862). GWAS including comorbid cases (MD-comorbid or ANX-comorbid) were used for comparison. Genetic correlations were compared by comorbidity status, and Mendelian randomization was employed to assess causal relationships. Results MD-comorbid and ANX-comorbid PRS showed stronger association with ANX-MD cases than with their primary disorders, MD-only (Z=-2.82; Padjusted=0.01) and ANX-only (Z=-2.36; Padjusted=0.03), respectively. MD-only PRS was more strongly associated with MD-only than with ANX-only cases (Z=3.63; Padjusted=6.9e-04). The genetic correlation was lower between ANX-only and MD-only (rg=0.53, SE=0.11) than between ANX-comorbid and MD-comorbid (rg=0.91, SE=0.01). Bidirectional causal effects observed in comorbidity-inclusive analyses were attenuated to null when comorbid states were excluded. Gene sets of MD-comorbid, ANX-comorbid, and MD-only, but not of ANX-only, were enriched for the immune regulation pathway -interleukin-21 production. Conclusions The genetic distinction between ANX and MD becomes more pronounced when comorbid cases are excluded. The findings underscore the importance of disorder-specific genetic studies for advancing precision medicine.